Morphine Sulfate Injection — Class II drug recall D-023-2014
Terminated recall by Hospira, Inc., reported 2013-12-11, distributed nationwide. Lack of Assurance of Sterility: Confirmed customer report of leakage of vial contents due to the breaking of t
| Recall number | D-023-2014 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Hospira, Inc., Lake Forest, IL, United States |
| Recall initiated | 2013-09-16 |
| Classified | 2013-12-02 |
| Reported by FDA | 2013-12-11 |
| Terminated | 2014-10-28 |
| Distributed | Nationwide (US) |
| Quantity | 29,700 vials |
| Reason classes | sterility, packaging |
| NDC | 00409-1135-02 |
| Lot numbers | 08/13, 17368EV |
Product
Morphine Sulfate Injection, USP, (25mg/mL), 250 mg, 10mL Fill, Single dosage Flip top Vial, (C-II), (NDC 0409-1135-02), Rx Only, Manfactured for Hospira, Inc., Lake Forest, IL 60045 USA.
Reason for recall
Lack of Assurance of Sterility: Confirmed customer report of leakage of vial contents due to the breaking of the vial neck.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-023-2014. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.